Calton & Associates’s Adamas Trust ADAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$130K Buy
13,806
+285
+2% +$2.45K 0.02% 415
2026
Q1
$99.5K Buy
13,521
+2,400
+22% +$19.1K 0.01% 430
2025
Q4
$81.2K Buy
+11,121
New +$78.9K 0.01% 439
2025
Q3
Sell
-10,662
Closed -$71.4K 449
2025
Q2
$71.4K Buy
+10,662
New +$67.6K 0.01% 380
2024
Q4
Sell
-12,955
Closed -$82K 254
2024
Q3
$82K Buy
+12,955
New +$83.4K 0.03% 236
2022
Q3
Sell
-2,546
Closed -$28K 238
2022
Q2
$28K Sell
2,546
-1,704
-40% -$20.9K 0.02% 234
2022
Q1
$62K Sell
4,250
-246
-5% -$3.6K 0.02% 344
2021
Q4
$66K Buy
4,496
+576
+15% +$9.44K 0.02% 361
2021
Q3
$66K Buy
3,920
+76
+2% +$1.32K 0.01% 391
2021
Q2
$69K Buy
3,844
+71
+2% +$1.29K 0.01% 401
2021
Q1
$67K Buy
3,773
+80
+2% +$1.32K 0.01% 392
2020
Q4
$55K Buy
3,693
+87
+2% +$1.1K 0.01% 377
2020
Q3
$37K Buy
3,606
+59
+2% +$615 0.01% 344
2020
Q2
$37K Sell
3,547
-500
-12% -$4.38K 0.01% 328
2020
Q1
$25K Buy
4,047
+1,547
+62% +$32.6K 0.01% 302
2019
Q4
$62K Buy
+2,500
New +$62K 0.01% 354

Other funds holding ADAM

Calton & Associates's ADAM Position: Q2 2026 in Review

Calton & Associates increased its Adamas Trust (ADAM) stake by 2.1% in Q2 2026, buying an estimated $2.45K and bringing the position to 13,806 shares worth $130K. The position accounts for 0.02% of the portfolio, ranked #415.

Calton & Associates first reported a position in ADAM in Q4 2019 and has held it in 16 quarters since. 207 funds tracked by Wall St. Rank hold ADAM as of Q2 2026.

  • Calton & Associates held 13,806 shares of Adamas Trust worth $130K as of Q2 2026.
  • Calton & Associates bought 285 Adamas Trust shares in Q2 2026, an estimated $2.45K.
  • Adamas Trust made up 0.02% of Calton & Associates's portfolio in Q2 2026, its #415 holding.
  • Calton & Associates first reported a position in Adamas Trust in Q4 2019 and has held it in 16 quarters since.
  • 207 funds tracked by Wall St. Rank held Adamas Trust as of Q2 2026.

Based on Calton & Associates's 13F filing for Q2 2026, filed 10 Aug 2026.